A hydroalcoholic (50%) extract of Emblica officinalis (fruit) (EO-50) reduced the severity of hepatic fibrosis induced by carbon tetrachloride (CCl 4 ) and thioacetamide (TAA). Improved liver function was observed by measuring the levels of aspartate aminotransaminase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and bilirubin in serum. Hepatic parameters monitored were the levels of glutathione (GSH), lipid peroxidation (LPO) and hydroxyproline and the activities of catalase, glutathione peroxidase (GPx), Na 
Fibrosis of the liver is a state of complicated end stage alteration of structure and function due to different etiologies. 1) There is no established therapy and the treatment options require long term administration of putative anti-fibrotics which must be free of side effects. Considerable efforts are being made to obtain useful herbal medicines from documented medicinal plants for a wide variety of clinical conditions. In Ayurveda, fruit of Emblica officinalis is considered a highly reputed drug for various ailments 2, 3) and has been in use as a cure for anaemia, liver diseases, dyspepsia, haemorrhage and diarrhoea. The fermented liquor prepared from fruits is used in jaundice. 4) In some studies its liver protective action has been documented. 5, 6) The present study was undertaken to evaluate whether a 50% hydroalcoholic extract of Emblica officinalis (fruit) exhibited anti-fibrotic activity in two independent experimental models of liver fibrosis induced by carbon tetrachloride (CCl 4 ) and thioacetamide (TAA). 4 and TAA Male Wistar rats (100Ϯ10 g) were kept (3/cage : 6/group) in the animal house of the Institute, under controlled conditions (temp. 26Ϯ2°C; relative humidity 50Ϯ5%; 12 h light/dark cycle). The animals were maintained on pelleted rodent diet (Ashirwad Industries Ltd., Chandigarh, India). Water was provided ad libitum. Animals received the toxin as well as the test materials at an interval of 1.0 h, between 8:00 a.m. and 10:00 a.m. after the animals were fed. Institutional Animal Ethics committee approved the animal experiments and the Guidelines for Animal Care were strictly adhered to as recommended by the Indian National Science Academy, New Delhi (1992). Fibrosis was induced, in one group of animals, by administering 25 ml CCl 4 (diluted 1 : 6 in vegetable oil)/100 g rat, i.p., 3 times weekly, for 10 weeks; while in other group of animals, by administering TAA, 200 mg/kg, i.p., twice weekly, for 12 weeks.
MATERIALS AND METHODS

Liver Fibrosis Induced by CCl
Preparation and Administration of EO-50 A 50% alcoholic extract (EO-50), was obtained from the fresh, finely cut fruits of Emblica officinalis as described previously.
5) The yield of dried residue was 3.9%. In several batches the dried residue was found to contain 33% (w/w) tannin content. EO-50 was administered at 100 mg/kg dose, p.o., once daily, as an aqueous suspension made in 0.5% gum acacia. Biochemical Analysis At the end of treatment schedules, samples (blood/liver) were collected 2 h after the administration of the test material between 8:00 a.m.-10:00 a.m.
Determinations of aspartate aminotransaminase (AST), alanine aminotransferase (ALT), lipid peroxidation (LPO), glutathione (GSH) and anti-oxidant activity (in vitro) were carried out as described previously.
7) The other assays included alkaline phosphatase (ALP), 8) and bilirubin (using a commercial kit from Zydus Pathline Ltd., India). Glutathione peroxidase (GPx) and catalase, 9) Na ϩ ,K ϩ -ATPase 10) were estimated in supernatants from a 10% liver homogenate (prepared in 1.5 M KCl). Hydroxyproline content was determined in liver tissues by the method of Jamall et al. 11) CYP 450 2E1 activity was determined as hydroxylation of aniline 12) in liver microsomes prepared by calcium precipitation method. 13) Protein was estimated by the method of Lowry et al. 14) The biochemicals were obtained from Sigma Chemical Co. U.S.A. All other chemicals were of high purity reagent grade.
Statistical Analysis Statistical comparisons were derived by two-way ANOVA and Student's t-test.
RESULTS
Compared to control values, CCl 4 and TAA treatment enhanced AST levels by 9-10 fold; ALP and bilirubin levels by 4-7 fold; ALT increase was 10 and 6 fold respectively in CCl 4 and TAA treated groups. In rats which were allowed to recover without any treatment (Groups B-II and C-II), these parameters recovered marginally (about 1.0-fold only) compared with toxin-treated groups (B-I and C-I). After treatment with EO-50 (100 mg/kg, p.o.) the decrease in these markers in CCl 4 and TAA treated group was between 3-5 fold (Table 1) .
Liver parameters are summarized in Tables 2A and 2B . In toxin treated groups (B-I and C-I) LPO levels increased by 3 fold; catalase activity was suppreseed by 3-4 fold; GPx ac-tivities and GSH content was reduced by 2 fold. In Group B-II and C-II rats, the changes in all these parameters were marginal (1.0 fold). EO-50 (100 mg/kg) treatment inhibited all these parameters in the range of 2 fold in presence of toxins (Table 2A) . A 2 fold reduction in Na ϩ ,K ϩ -ATPase was observed (Table 2A) . Hydroxyproline content increased by 3-5 fold whereas CYP2E1 activity increased by 2-3 fold. In Group B-II and C-II rats, these changes were only 1 fold, whereas EO-50 (100 mg/kg) reversed these parameters in the range of 2-3 fold. Table 3 shows liver/body weights ratio. An increase in the range of 1.3-1.6 fold was recorded in rats treated both with CCl 4 and TAA. When the rats were allowed to recover without any treatment the liver/body weights ratios improved only marginally (by 11%) whereas EO-50 produced 92% effect. In vitro effect of EO-50 (20-100 mg/ml) on scavenging of superoxide anion radical produced in (a) enzymic and (b) non-enzymic systems is shown in Fig. 1 . In enzymic assay 63-78% scavenging effect was observed while in non-enzymic assay 53-82% effect was recorded.
DISCUSSION
A large amount of evidences suggest oxidative stress as a major mechanism that remains in focus in the etiology of fibrosis. 15) Excess oxygen derived free radicals (ODFR) play a major mediatory role in inducing synthesis of fibrillar extracellular matrix. 16) ODFR cause peroxidation of membrane lipids which consistently lower the GSH content of the cell which deprives cell of one of the most important defense systems in the liver. Besides serving as a substrate for related enzymes such as GPx, GSH acts as a ODFR scavenger and plays an important role in the maintenance of protein sulfhydryl groups. GSH also protects against CYP2E1 de- Forty two rats were divided into 7 groups (6/group). Gr A, control (vehicle); Gr B-I and C-I, toxin control (sacrificed 3 d after last dose of respective toxin). Rest of the toxin treated groups were maintained for a further 5 weeks during which Gr B-II and C-II animals received vehicle only and were allowed to recover without any treatment. Gr B-III and C-III animals received EO-50 (100 mg/kg, p.o. pendent cytotoxicity. 16) Both GPx and catalase activities are decreased with the onset and progression of fibrosis.
17) The reduction in the activity of membrane bound enzymes Na ϩ ,K ϩ -ATPase is another manifestation of fibrotic action of CCl 4 and TAA reflecting a membrane disrupting effects of ODFR. 18) In the present study two models of hepatic fibrosis induced by CCl 4 and TAA have been used. Exposure to both CCl 4 and TAA is reported to induce CYP 450 2E1 which is principally involved in the toxicokinetic mechanism of these fibrotic agents, 19) and remains localised in perivenous lobules and happens to be is a major source of ODFR. 20) Although liver is endowed with a unique capacity to regenerate thereby replenishing most of the protective systems, fibrotic tissue represent a situation where anti-oxidant capacity is insufficient to cope with the generation of pro-oxidants. Under these circumstances exogenous use of herbal antifibrotics with additional attribute of their anti-oxidant activity seem important. The results showed that EO-50 acted not only as scavenger of ODFR at the initiation phase (whether the superoxides are generated by a enzymic or a non-enzymic reaction) and but also at the terminal stage suppressing lipid peroxidation. Emblica officinalis (fruit) has also been shown earlier to possess potent anti-oxidant activity. 21) This could be one of the important biochemical events contributing in attenuation of fibrotic changes as observed in decreased levels of hydroxyproline in the livers of CCl 4 and TAA challenged rats receiving EO-50. Earlier a similar finding where an aqueous extract of Emblica officinalis reversed the CCl 4 -induced increase in hydroxyproline levels in liver was documented.
6) An abnormal liver-to-body weight ratio recorded in CCl 4 and TAA treated rats was significantly reversed after treatment with EO-50. Upregulation of GSH as a result of treatment with EO-50 possibly contributed to the attenuation of CYP2E1-dependent oxidative stress and toxicity. A considerable restoration of Na ϩ ,K ϩ -ATPase activity indicated a membrane stabilizing activity of the test extract.
In conclusion, the antifibrotic activity of EO-50 could be attributed to its mechanistic intervention with several cellular events to provide beneficial effects against this multifactorial process of fibrogenesis, most importantly by (a) attenuating the oxidative stress (b) stabilizing the membrane against fibrotic challenge (c) preventing from the the CYP2E1 mediated bioactivation.
Emblica offcinalis (fruit) is reported to contain innumerable constituents in varying amounts falling in broad classes of alkaloids, benzenoid derivatives, di-, and triterpenes, furanolactones, flavonoids and sterols. 22) The development of antifibrotic agents devoid of side effects seems important and we are continuing our investigations to identify novel herbal entities responsible for the unique antifibrotic action of Emblica offcinalis (fruit).
